Table 1 Patient and tumour characteristics
From: 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer
Ductal carcinoma ( n =140) | Lobular carcinoma ( n =25) | Other carcinomas ( n =8) | Total ( n =173) | |
|---|---|---|---|---|
Average age (years) | 56.4±12.1 | 58.2±16.7 | 66.5±13.3 | 57.1±13.0 |
Grade | ||||
I | 18 (12.9%) | 2 (8%) | 7 (87.5%) | 26 (15.6%) |
II | 64 (45.7%) | 19 (76%) | 1 (12.5%) | 83 (48.6%) |
III | 58 (41.4%) | 4 (16%) | 0 (0%) | 62 (35.8%) |
T | ||||
1 | 89 (63.6%) | 16 (64%) | 5 (62.5%) | 110 (63.6%) |
2 | 44 (31.4%) | 8 (32%) | 3 (37.5%) | 55 (31.8%) |
3+4 | 7 (5%) | 1 (4%) | 0 (0%) | 8 (4.7%) |
N | ||||
0 | 75 (53.6%) | 14 (56%) | 8 (100%) | 97 (56.1%) |
1 | 58 (41.4%) | 8 (32%) | 0 (0%) | 66 (38.2%) |
2 | 7 (5%) | 3 (12%) | 0 (0%) | 10 (5.8%) |
HER-2 | ||||
Positive | 20 (14.3%) | 2 (8%) | 0 (0%) | 22 (12.7%) |
Negative | 120 (85.7%) | 23 (92%) | 8 (100%) | 151 (87.3%) |
Estrogen receptor | ||||
Positive | 107 (76.4%) | 25 (100%) | 8 (100%) | 140 (80.9%) |
Negative | 33 (23.6%) | 0 (0%) | 0 (0%) | 33 (19.1%) |
Progesterone receptor | ||||
Positive | 90 (64.3%) | 19 (76%) | 7 (87.5%) | 116 (67.1%) |
Negative | 50 (35.7%) | 6 (24%) | 1 (12.5%) | 57 (32.9%) |
Lymphatic vessel invasion | ||||
Yes | 15 (10.7%) | 0 (0%) | 1 (12.5%) | 16 (9.2%) |
No | 119 (85.0%) | 25 (100%) | 7 (87.5%) | 151 (87.3%) |
Unknown | 6 (4.3%) | 6 (3.5%) | ||
Blood vessel invasion | ||||
Yes | 9 (6.4%) | 0 (0%) | 0 (0%) | 9 (5.2%) |
No | 125 (89.3%) | 25 (100%) | 8 (100%) | 158 (91.3%) |
Unknown | 6 (4.3%) | 6 (3.5%) | ||
Treated with | ||||
Radiotherapy | 131 (93.6%) | 23 (92%) | 4 (50%) | 158 (91.3%) |
Chemotherapy | 75 (53.6%) | 7 (28%) | 0 (0%) | 82 (47.4%) |
Hormonal therapy | 60 (42.9%) | 10 (40%) | 0 (0%) | 70 (40.5%) |
